qtern compresse rivestite con film
astrazeneca ag - dapagliflozinum, saxagliptinum - compresse rivestite con film - dapagliflozinum 10 mg ut dapagliflozinum propandiolum monohydricum, saxagliptinum 5 mg ut saxagliptini hydrochloridum, cellulosum microcristallinum, lactosum 40 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidum hydrochloridum, natrii hydroxidum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: e 132, lacca, pro compresso obducto corresp. natrium max. 0.91 mg. - antidiabetico - synthetika
tacforius
teva b.v. - tacrolimus monoidrato - liver transplantation; kidney transplantation - immunosoppressori - profilassi del rigetto del trapianto in pazienti adulti trapiantati di fegato o rene. trattamento del rigetto dell'allotrapianto resistente al trattamento con altri medicinali immunosoppressivi nei pazienti adulti.
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
itragerm
isdin s.r.l. - itraconazolo - itraconazolo
keymet
i.b.n. savio s.r.l - metformina - metformina
bosulif 400 mg compresse rivestite con film
pfizer ag - bosutinibum - compresse rivestite con film - bosutinibum 400 mg ut bosutinibum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.31 mg, poloxamerum 188, povidonum k 25, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto. - onkologikum - synthetika
qtrilmet
astrazeneca ab - la metformina cloridrato, saxagliptin, dapagliflozin - diabete mellito, tipo 2 - farmaci usati nel diabete - qtrilmet è indicato negli adulti dai 18 anni di età con diabete mellito di tipo 2:migliorare il controllo glicemico quando metformina con o senza sulfonilurea (su) e saxagliptin o dapagliflozin non forniscono un adeguato controllo glicemico. quando già in trattamento con metformina e saxagliptin e dapagliflozin.
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - agenti antineoplastici - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenti antineoplastici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
alunbrig 30 mg compresse rivestite con film
takeda pharma ag - brigatinibum - compresse rivestite con film - brigatinibum 30 mg, lactosum monohydricum 56.06 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 126 - 189 µg, silica hydrophobica colloidalis, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), e 171 pro compresso obducto. - non tumori polmonari a piccole carcinoma polmonare (nsclc) - synthetika